Post by smartbax

We’re excited to announce the successful first closing of our €4.7 million Pre-Series A financing round, led by Anobis Asset and Bayern Kapital, with participation from UnternehmerTUM Funding for Innovators, as well as existing investors HTGF | High-Tech Gründerfonds and Boehringer Ingelheim Venture Fund. This funding will enable us to advance our lead antibiotic candidate targeting a novel mechanism in Gram-negative bacteria through preclinical development, and to further develop our innovative platform of small-molecule enzyme activators designed to trigger bacterial self-digestion. We thank our investors for their trust and commitment to our mission of tackling antimicrobial resistance with next-generation antibiotics. Read the full press release here: https://lnkd.in/eS-Hcb2k